The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 22, 2018

Filed:

Sep. 11, 2013
Applicants:

Addanki Pratap Kumar, San Antonio, TX (US);

Izhar Singh Batth, San Antonio, TX (US);

Rita Ghosh, San Antonio, TX (US);

Roble Bedolla, San Antonio, TX (US);

Ian M. Thompson, Jr., San Antonio, TX (US);

Inventors:

Addanki Pratap Kumar, San Antonio, TX (US);

Izhar Singh Batth, San Antonio, TX (US);

Rita Ghosh, San Antonio, TX (US);

Roble Bedolla, San Antonio, TX (US);

Ian M. Thompson, Jr., San Antonio, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/50 (2006.01); G01N 33/574 (2006.01); A61K 31/58 (2006.01); A61K 39/00 (2006.01); G01N 33/68 (2006.01); A61K 31/337 (2006.01); A61K 31/573 (2006.01); A61K 31/137 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); A61K 31/137 (2013.01); A61K 31/337 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 39/0011 (2013.01); G01N 33/57434 (2013.01); G01N 2333/4706 (2013.01); G01N 2800/54 (2013.01);
Abstract

Certain embodiments are directed to methods of identifying a subject having a higher risk of prostate cancer recurrence. The methods can include the step of measuring levels of one or more of FLIP, transcription factor Sp1, and transcription factor Sp3 in a prostate sample from the subject, wherein elevated levels of FLIP, transcription factor Sp1, and transcription factor Sp3 identify a subject as high risk for prostate cancer recurrence.


Find Patent Forward Citations

Loading…